Caliper Life Sciences last week announced two separate deals, one with Yale University's Center for Genome Analysis and another with Erasmus University Medical Center, to automate sample prep for next-generation sequencing projects.
The company disclosed the agreements prior to PerkinElmer's announcement that it plans to acquire Caliper in a deal worth approximately $600 million (see related story, this issue).
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
